|
MRPL41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.883400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.281300E-03 |
| Normal-vs-Stage2 |
2.077100E-03 |
| Normal-vs-Stage3 |
2.901900E-02 |
| Normal-vs-Stage4 |
3.517000E-01 |
| Stage1-vs-Stage2 |
9.068400E-02 |
| Stage1-vs-Stage3 |
8.695400E-01 |
| Stage1-vs-Stage4 |
1.192200E-01 |
| Stage2-vs-Stage3 |
9.428200E-02 |
| Stage2-vs-Stage4 |
1.611650E-02 |
| Stage3-vs-Stage4 |
2.256400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.235600E-03 |
| Normal-vs-AfricanAmerican |
4.116000E-01 |
| Normal-vs-Asian |
3.066800E-01 |
| Caucasian-vs-AfricanAmerican |
4.008800E-01 |
| Caucasian-vs-Asian |
2.799400E-01 |
| AfricanAmerican-vs-Asian |
9.721200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.358600E-03 |
| Normal-vs-Female |
1.201850E-02 |
| Male-vs-Female |
1.894360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.055100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.571950E-02 |
| Normal-vs-Age(61-80Yrs) |
2.747700E-02 |
| Normal-vs-Age(81-100Yrs) |
4.891600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.009600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.341400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.739200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.861400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.975200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.437600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.122600E-01 |
| Classical-VS-Follicular |
3.6915999999998E-05 |
| Classical-VS-Other |
1.743770E-01 |
| Classical-VS-Normal |
1.546420E-01 |
| Tall-VS-Follicular |
1.451790E-02 |
| Tall-VS-Other |
7.496400E-02 |
| Tall-VS-Normal |
5.268000E-01 |
| Follicular-VS-Other |
6.085600E-01 |
| Follicular-VS-Normal |
3.76059999995793E-06 |
| Other-VS-Normal |
1.179790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.611920E-04 |
| Normal-vs-N1 |
3.799200E-03 |
| N0-vs-N1 |
6.496400E-01 |
|
|
